Member Info for Wildforce

Pepe .. I recommend a visit indeed. I was there for pirate weekend on the bank holiday just gone .. crazy lol … and if you are lucky enough to get a clear morning .. go watch the sunrise from out on the end of the berry head .. one of the best places to see one! And if you are lucky you will see dolphins too !!

Take care !

Ripley .. did have a chuckle at that advice ! Makes it sound so easy lol !

Take care ..

Morning ! Rare off topic post from me but I saw you mention Cirl Buntings … There is one place in the uk you can see them… Berry Head in Devon .. a tiny population is still clinging on year round .. they are stunning little things indeed ..

Take care all ..

Come on you two .. lol .. bury the hatchet, exciting times at scancell …

Take care both ..

Morning Chester ! I think more than Zak .. the rising share price itself with be something that it noticed … when I see a rising share price .. first thing I do is look at the companies RNS’s … just to see if it’s fluff and the herd or to see if it’s something significant ….

Take care all ..

Great holding sid … good work . Anyone who holds over a million shares must be very very confident Scancell will deliver … me too !

Take care ..

.. or sold out too early cos their charts told them too ??

Risky business that ..

Take care all ..

Read scancells last RNS.

Take care ..

Good job scancell have an exquisite advisory board .. I’m confident they know the best way forward.

Take care and thanks again ..

Thanks berm .. I wonder if they could include an arm with Keytruda at all ?

Will be interesting to see when trial design is disclosed.

Take care ..

Note .. at 20 months in iscib1+ phase 2 .. 77% still hadn’t progressed .. median pfs not yet reached .. wow ..

Take care all ..

I was just looking at the data for the nivo ipi combination trial. Here are some findings ..

“In the phase 3 CheckMate 067 trial for advanced melanoma, the median progression-free survival (PFS) was 11.5 months for nivolumab plus ipilimumab, 6.9 months for nivolumab alone, and 2.9 months for ipilimumab alone. The combination therapy showed significantly improved long-term PFS and OS compared to ipilimumab monotherapy.”

Correct me if I’m wrong (Berm) but the planned registrational phase 3 trial for iscib1 combo will use this standard of care as its control arm ?

I’ll get to the point … late stage melanoma is very nasty indeed and should the registrational phase 3 trial of iscib1+ perform as well as the phase 2, then we could see iscib1+ being given as part of the standard of care in not the too distant future !

As mentioned, it’s heartbreaking these things can’t be done more quickly … but due process has to be followed unfortunately ..

Also worth remembering, iscib1+ is the first of a few immunobody vaccines .. prove one, derisk the others !?

Take care all !

I echo berms sentiments.. that is very young ..

Take care ..

I’m here for the knock your socks off science and the data that is supporting it .. I couldn’t care less about others’ behaviour or charts. A tiny amount of research will show that scancell is way undervalued compared to other global biotech at its stage. But as ever only my opinion, do your own research … do not take my word for it. Trade away if you like .. but too risky for me !

Take care all ..

Violin .. day trading and charting are not for the faint hearted … look up the 90 90 90 rule …

Take care all..

Trading is an odds game … investing is an intelligence occupation.

Good luck everyone! If it’s luck you rely on ?

Take care all ..

GF .. I’m guessing scancell may well have options on their next move ..

Just reading down that list of recent RNS’s, how did none of them move the market !! Astonishing really.

Take care ..

Vanvan .. just my opinion but the rise is a delayed aim reaction to some fantastic recent RNS’s that at the time did not move the market ? But they are now !!

Still way off where it should be ..

Next news will be interesting !!

Take care all ..

Morning all .. quick question .. was the addition of Eric Rubin to the advisory board ever ‘announced’ anywhere? Because, for me, it’s absolutely enormous that someone with such an incredible background in immunotherapy would want to have his name associated with little old scancell. That for me alone, secures my shares even further.

Take care all ..

Sid … Immunicorn .. lol .. brilliant !

Take care ..